The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer.
 
Peter C. Enzinger
Consulting or Advisory Role - Astellas Pharma; Five Prime Therapeutics; Merck; Taiho Pharmaceutical
 
Nadine Jackson McCleary
No Relationships to Disclose
 
Nora Horick
No Relationships to Disclose
 
James M. Cleary
Honoraria - Agios
Research Funding - Merck
Travel, Accommodations, Expenses - Agios; Roche
 
Douglas Adam Rubinson
No Relationships to Disclose
 
Bridget Fitzpatrick
No Relationships to Disclose
 
Christopher Graham
No Relationships to Disclose
 
Jeffrey W. Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Anuj K. Patel
No Relationships to Disclose
 
Eirini Pectasides
No Relationships to Disclose
 
Kimberly Perez
No Relationships to Disclose
 
Matthew B. Yurgelun
Research Funding - Myriad Genetics
 
Christopher G. Azzoli
Consulting or Advisory Role - ARIAD/Takeda; Merck
 
Andrea Catherine Enzinger
Consulting or Advisory Role - Amgen (I); Five Prime Therapeutics (I); Merck (I); Pfizer (I); Sirtex Medical (I)
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Loxo; Takeda; Theravance
Research Funding - Adaptimmune (Inst); ARIAD; AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Affymetrix
 
Benjamin L. Schlechter
No Relationships to Disclose
 
Jeffrey A. Meyerhardt
Honoraria - Chugai Pharma; Ignyta
Consulting or Advisory Role - Genentech/Roche
 
Kimmie Ng
Consulting or Advisory Role - Bayer; Genentech/Roche; Lilly; Tarrex Biopharma
Research Funding - Celgene; Genentech/Roche (Inst); Gilead Sciences; Pharmavite (Inst); Trovagene
 
Adam Joel Bass
Leadership - Strand Life Sciences
Consulting or Advisory Role - Lilly
Research Funding - Onkaido Therapeutics; Sanofi
Travel, Accommodations, Expenses - Lilly
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical